ArticleBioengineering & translational medicine2026

Neuron-targeted 2-deoxyglucose-dendrimer-rosiglitazone nanotherapy mitigates neuroinflammation and cognitive deficits in pediatric traumatic brain injury.

Aqib Iqbal Dar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.